Methadone Maintenance Treatment vs. Long-Term Abstinence Without Opioid Agonist: Epigenome-Wide Study of DNA Methylation
Orna Levran, Justin Li, Anat Sason, Miriam Adelson, Einat Peles · 2026
Read Methadone Maintenance Treatment vs. Long-Term Abstinence Without Opioid Agonist: Epigenome-Wide Study of DNA Methylation by Orna Levran, Justin Li, Anat Sason, Miriam Adelson, Einat Peles (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214831.txt.
Description
Orna Levran and co-authors compare gene marks between two paths out of opioid addiction in a 2026 paper. One group stays on methadone, a daily drug that blocks cravings. The other group has stayed clean for over ten years with no such drug. Chemical marks on DNA, which tune gene activity, may differ between the two paths.
Blood DNA from 114 people on methadone and 136 people long abstinent was read on a chip that scans the whole genome. A total of 135 mark sites differed at a strict level of proof. The sites map to 157 genes, many of them long non-coding genes. The pattern may hint at how each route reshapes the body's gene settings.
Catalog record
| CREATOR | Orna Levran, Justin Li, Anat Sason, Miriam Adelson, Einat Peles |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |